Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.
Jean-Pierre QuenotJulie HelmsAbderrahmane BourredjemAuguste DargentFerhat MezianiJulio BadieGilles BlascoGaël PitonGilles CapellierChaouki MezherJean-Michel RebibouAbdelouaid NadjiThomas CrepinSaber Davide BarbarCamille FleckAmélie CransacMathieu BoulinChristine BinquetAgnès Soudry-FaureRémi Bruyèrenull nullPublished in: Annals of intensive care (2019)
In critically ill patients, there was no significant difference in the duration of event-free survival of the first non-tunneled hemodialysis catheter between trisodium citrate 4% and heparin as a locking solution. Catheter thrombosis, catheter-related infection, and adverse events were not statistically different between the two groups. Trial registration Registered with Clinicaltrials.gov under the number NCT01962116. Registered 14 October 2013.